These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1828048)

  • 1. Drug-induced immune complex disease.
    Sim E
    Biochem Soc Trans; 1991 Feb; 19(1):164-70. PubMed ID: 1828048
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced immune-complex disease.
    Sim E
    Complement Inflamm; 1989; 6(2):119-26. PubMed ID: 2524348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procainamide, acetylprocainamide, and drug-induced lupus erythematosus.
    Bernstein RE
    Lancet; 1979 Nov; 2(8151):1076. PubMed ID: 91813
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of complement in the aetiopathogenesis of systemic lupus erythematosus.
    Gatenby PA
    Autoimmunity; 1991; 11(1):61-6. PubMed ID: 1839881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.
    Speirs C; Fielder AH; Chapel H; Davey NJ; Batchelor JR
    Lancet; 1989 Apr; 1(8644):922-4. PubMed ID: 2565418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and complement receptors in systemic lupus erythematosus.
    Atkinson JP
    Springer Semin Immunopathol; 1986; 9(2-3):179-94. PubMed ID: 3544279
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement activation and vascular injury in systemic lupus erythematosus.
    Abramson S; Belmont HM; Hopkins P; Buyon J; Winchester R; Weissmann G
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():43-6. PubMed ID: 2886660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydralazine binds covalently to complement component C4. Different reactivity of C4A and C4B gene products.
    Sim E; Law SK
    FEBS Lett; 1985 May; 184(2):323-7. PubMed ID: 3873356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-penicillamine and immune complex deposition.
    Kirby JD; Dieppe PA; Huskisson EC; Smith B
    Ann Rheum Dis; 1979 Aug; 38(4):344-6. PubMed ID: 159020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenetic significance of circulating immune complexes.
    Van Es LA; Daha MR; Valentijn RM; Kauffmann RH
    Neth J Med; 1984; 27(9):350-8. PubMed ID: 6083461
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune complex glomerulonephritis in hydralazine-induced SLE.
    Shapiro KS; Pinn VW; Harrington JT; Levey AS
    Am J Kidney Dis; 1984 Jan; 3(4):270-4. PubMed ID: 6229178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced systemic lupus erythematosus.
    Stratton MA
    Clin Pharm; 1985; 4(6):657-63. PubMed ID: 2866863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug effects on autoantibodies and immune complexes.
    Holborow EJ
    Agents Actions Suppl; 1980; 7():58-61. PubMed ID: 6972690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement deficiency and the pathogenesis of autoimmune immune complex disease.
    Lachmann PJ
    Chem Immunol; 1990; 49():245-63. PubMed ID: 2140942
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs that induce systemic lupus erythematosus inhibit complement component C4.
    Sim E; Gill EW; Sim RB
    Lancet; 1984 Aug; 2(8400):422-4. PubMed ID: 6147500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the metabolism of C4 isotypes in patients with complement activation.
    Peake PW; Pussell BA; Charlesworth JA; Gavrilovic L; Timmermans V
    Clin Exp Immunol; 1989 Oct; 78(1):49-53. PubMed ID: 2530015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs.
    Lu Q; Wu A; Richardson BC
    J Immunol; 2005 May; 174(10):6212-9. PubMed ID: 15879118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum complement activation pathways and circulating anti-streptolysin-0 antibodies: diagnostic value in glomerulonephritis in children].
    Rabhi H; Ghaffor M; Salah-Salah H; Abbadi MC
    Arch Inst Pasteur Alger; 1986; 55():99-105. PubMed ID: 2978952
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune complex injury of the lung. Symposium held at the 74th annual meeting of the American Thoracic Society, Las Vegas, Nevada, May 1979.
    Daniele RP; Henson PM; Fantone JC; Ward PA; Dreisin RB
    Am Rev Respir Dis; 1981 Dec; 124(6):738-55. PubMed ID: 6459046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.